DericMinwooParkMDFACP
Neurology • Hackensack, NJNeurooncology
Professor and Chief, Neuro-Oncology Division
Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
92 2nd Street
Hackensack, NJ 07601Phone+1 551-996-5900- Is this information wrong?
Education & Training
NIH Clinical CenterCell Biology-Immunology, 2002 - 2007
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2000 - 2002
University of ChicagoChief Residency, Neurology, 1999 - 2000- University of ChicagoResidency, Neurology, 1997 - 2000
- University of Chicago (NorthShore)Internship, Transitional Year, 1996 - 1997
Loma Linda University School of MedicineClass of 1996- Loma Linda UniversityPost-Sophomore Fellow, Pathology, 1993 - 1994
Certifications & Licensure
IL State Medical License 2018 - 2026- IL State Medical License 1996 - 2026
NJ State Medical License 2023 - 2025
PA State Medical License 2007 - 2010
NY State Medical License 2000 - 2008- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- Merit and Career Development Awards American Society of Clinical Oncology
Clinical Trials
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma Start of enrollment: 2011 Oct 01
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma Start of enrollment: 2015 Apr 17
- Biomarker Analysis of Central Nervous System Tumors Start of enrollment: 2016 Feb 25
- Join now to see all
Publications & Presentations
PubMed
- TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.Li, A., Hancock, J., Quezado, M., Ahn, S., Briceno, N., Celiku, O., Ranjan, S., Aboud, O., Colwell, N., Kim, S., Nduom, E., Kuhn, S., Park, D., Vera, E., Aldape, K., A...> ;Neuro-Oncology Advances. 2023 Dec 19
- 4 citationsA Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1.Yuxuan Deng, Boyi Hu, Yazhou Miao, Jing Wang, Shaodong Zhang, Hong Wan, Zhen Wu, Yifan Lv, Jie Feng, Nan Ji, Deric Park, Shuyu Hao> ;Frontiers in Oncology. 2022 Jan 1
- Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants.Heather L. Smith, John Collins, Deric M. Park, Wendy Darlington, Martha Quezado, Kenneth Aldape, Peter C. Warnke, Peter Pytel> ;Journal of Neuropathology and Experimental Neurology. 2021 Sep 15
- Join now to see all
Journal Articles
- Clinical Decision Making in the Era of Immunotherapy for High Grade-Glioma: Report of Four CasesMartha Quezado, Brett J Theeler, Deric M Park, Edjah Nduom, Nancy Garren, Surabhi Ranjan, Kareem A Zaghloul, BioMed Central
Professional Memberships
- Fellow
Other Languages
- Korean
Hospital Affiliations
Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
Industry Relationships
- Scientific Advisor, Innate Repair2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
